White Paper: Digital Drug Companions Create Millions for Pharma

Supporting patient engagement is not only a growing strategic initiative for pharma companies but is proving to be an impactful value driver.

In today’s competitive world of pharma brands, with a narrowing share of patients and contrasting engagement channels, advanced digital solutions offer new opportunities to create value and build loyalty that leads to greater persistence and improved outcomes.

This paper describes how today’s next-gen digital solutions can deliver meaningful results for patients, providers, and pharma organizations when they have five critical elements:

  1. Personalized engagement using AI
  2. Scalability
  3. Patient-centric messaging
  4. Adaptable and integrated platform
  5. Enhanced real-world evidence

Click here to see the white paper (no registration required):
Transforming How Pharma Delivers Value

You may also like

PDURS: 7 Experts to Follow As the Draft FDA Guidelines Progress

Want to keep current on the FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS)? Follow the LinkedIn profiles 

..Read More

PDURS: What Four Top Law Firms Are Saying

The FDA’s draft guidelines for Prescription Drug Use Related Software (PDURS) have drawn significant attention from the legal community. Law 

..Read More

PDURS: How 7 Companies and Groups Responded to the Draft Guidelines

The FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS) have sparked considerable discussion among various stakeholders, including pharmaceutical 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.